CARA Digital Mailroom 31 July 2024 By Cei Ansley Consolidate physical mail and email with the CARA Platform. Our Digital Mailroom provides a comprehensive solution for adding workflows, out…
CDCR Upgrades Document and Records Management Processes with Generis’ CARA Platform 3 June 2024 By Cei Ansley June 4 2024 – California, USA – Generis, creator of the cloud data, content and business process management platform CARA™,…
A New Generation at the Helm: Interviewing the New CEO of Generis 23 May 2024 By Cei Ansley Announced first to customers and partners at our Generate 2024 Conference, former COO Max Kelleher will step up to take…
CARA Version 5.11: Key Features and Enhancements 17 May 2024 By Cei Ansley CARA Version 5.11 comes packed with 54 new features and enhancements, including a number of major features and plenty of…
Generis Welcomes Max Kelleher as New Chief Executive Officer 13 May 2024 By Cei Ansley 14th May, 2024 – London, England – Generis, creator of the cloud data, content, and business process management platform CARA™,…
The Role of Business Process Management in Digital Transformation 12 February 2024 By Cei Ansley So your organisation is embarking on a digital transformation initiative, but what does it involve? Yes, you’re shifting away from…
Leveraging Innovative Solutions to Enable Digital Transformation with Generis and Userlane 7 February 2024 By Cei Ansley The sweeping trend of digital transformation has infiltrated modern regulated enterprises across the world. Thanks to solutions sporting functionality such…
Swixx Biopharma Consolidates QMS, RIM, and Safety Processes with the CARA Life Sciences Platform 11 January 2024 By Cei Ansley Generis, creator of the cloud data, content, and business process management platform CARA™, announces that Swixx BioPharma has selected the…
CARA Hub – Collaborate with Partners on Controlled Content & Data 8 January 2024 By Cei Ansley Between the setup and decommissioning of partners, version control issues, and lack of security for data and documents, we know…
Lifesciences